NUTEMPEROR Xenotransplantation ベアトップ トップス,Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial - Annals of Oncology,Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5 | Oncogene,Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo | Biological Procedures Online | Full Text,Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14) | npj Precision Oncology,